Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives
- PMID: 26568335
- DOI: 10.1016/j.jaad.2014.08.051
Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives
Abstract
Leishmaniasis is endemic in 98 countries and territories, with 1.2 million new cases per year, making it a worldwide concern. The deadly visceral form is a leading cause of death from tropical parasitic infections, second only to malaria. Leishmaniasis appears to be increasing in many countries because of extended urbanization. The disease reservoir includes small mammals; parasite transmission occurs via bite of the female phlebotomine sandfly. Disease manifestations vary and largely depend upon the Leishmania species acquired. It may be first evident with a range of findings-from a localized cutaneous ulcer to diffuse painless dermal nodules-or, in the mucocutaneous form, ulceration of the oropharynx. In the potentially deadly visceral form, the internal organs and bone marrow are affected.
Keywords: bat; dog; gerbil; kala-azar; leishmaniasis; parasitic disorders; protozoan diseases; rodents; sandfly; tropical diseases; ulcer.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
